Rankings
▼
Calendar
TEVA FY 2013 Earnings — Teva Pharmaceutical Industries Limited Revenue & Financial Results | Market Cap Arena
TEVA
Teva Pharmaceutical Industries Limited
$35B
FY 2013 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$20.3B
-0.0% YoY
Gross Profit
$10.7B
52.7% margin
Operating Income
$1.6B
8.1% margin
Net Income
$1.3B
6.2% margin
EPS (Diluted)
$1.49
Cash Flow
Operating Cash Flow
$3.2B
Free Cash Flow
$2.2B
Stock-Based Comp.
$64M
Balance Sheet
Total Assets
$47.5B
Total Liabilities
$24.9B
Stockholders' Equity
$22.6B
Cash & Equivalents
$1.0B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$20.3B
$20.3B
-0.0%
Gross Profit
$10.7B
$10.7B
+0.5%
Operating Income
$1.6B
$2.2B
-25.2%
Net Income
$1.3B
$2.0B
-35.4%
← FY 2012
All Quarters
FY 2014 →